NCT03534947 2025-12-16
SONIB
Melanoma Institute Australia
Phase 2 Completed
Clinical Trials
10 trialsNCT00314756 2023-08-22
Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage
Wake Forest University Health Sciences
Phase 4 Completed
NCT00189280 2022-02-22
Aldara for the Treatment of Large and/or Multiple sBCC
Viatris Inc.
Phase 3 Completed
NCT00189241 2022-02-07
A Study to Evaluate Effectiveness of Imiquimod 5% Cream in Superficial Basal Cell Carcinoma
Viatris Inc.
Phase 3 Completed
NCT00066872 2013-09-17
Topical Imiquimod Compared With Surgery in Treating Patients With Basal Cell Skin Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00079300 2013-04-26
Imiquimod Cream in Treating Patients With Basal Cell Skin Cancer
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT00581425 2013-01-25
Intron-A/Aldara Combination Therapy for Basal Cell Carcinoma (BCC)
The University of Texas Health Science Center, Houston
Phase 4 Completed
NCT01212562 2011-09-02
IMCX
University of Ioannina
Completed
NCT00204555 2011-09-01
Safety and Efficacy Study of Imiquimod 5% Cream Applied 3x Per Week for 8 or 12 Weeks in Low Risk Nodular Basal Cell Carcinoma
University Hospital Tuebingen
Phase 4 Completed
NCT00129519 2010-07-16
A Study to Evaluate the Effectiveness of Imiquimod 5% Cream for Basal Cell Carcinoma Recurrence
Graceway Pharmaceuticals, LLC
Phase 3 Completed